Related Experiment Video
Updated: Apr 11, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Blinding in pharmaceutical clinical trials: An overview of points to consider
1GlaxoSmithKline R&D, United Kingdom.
Abstract:
Blinding is a corner-stone for the robustness of many clinical trials. Achieving a robust level of trial blinding involves close partnership across a number of trial disciplines, and numerous challenges can arise. This paper provides a wide-ranging overview of issues to consider in managing blinding, including clinical and statistical considerations, supply planning and inventory management strategy, and the management and disclosure of unplanned unblinding events that arise during trial conduct.
Related Concept Videos
Blinding
Blind Procedures
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Bioavailability Study Design: Healthy Subjects Versus Patients

